Selective induction of Rab9-dependent alternative mitophagy using a synthetic derivative of isoquinoline alleviates mitochondrial dysfunction and cognitive deficits in Alzheimer's disease models. The gene discussed is RAB9A; the disease is early-onset autosomal dominant Alzheimer disease.